AU4422797A - Methods and compositions for generating angiostatin - Google Patents
Methods and compositions for generating angiostatinInfo
- Publication number
- AU4422797A AU4422797A AU44227/97A AU4422797A AU4422797A AU 4422797 A AU4422797 A AU 4422797A AU 44227/97 A AU44227/97 A AU 44227/97A AU 4422797 A AU4422797 A AU 4422797A AU 4422797 A AU4422797 A AU 4422797A
- Authority
- AU
- Australia
- Prior art keywords
- fragments
- plasminogen
- provides
- plasminogen activator
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title abstract 8
- 102000012936 Angiostatins Human genes 0.000 title abstract 3
- 108010079709 Angiostatins Proteins 0.000 title abstract 3
- FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 125000003396 thiol group Chemical group [H]S* 0.000 abstract 6
- 102000001938 Plasminogen Activators Human genes 0.000 abstract 5
- 108010001014 Plasminogen Activators Proteins 0.000 abstract 5
- 201000010099 disease Diseases 0.000 abstract 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 5
- 229940127126 plasminogen activator Drugs 0.000 abstract 5
- 230000002491 angiogenic effect Effects 0.000 abstract 4
- 239000012634 fragment Substances 0.000 abstract 4
- 108010088842 Fibrinolysin Proteins 0.000 abstract 3
- 102000013566 Plasminogen Human genes 0.000 abstract 3
- 108010051456 Plasminogen Proteins 0.000 abstract 3
- 229940012957 plasmin Drugs 0.000 abstract 3
- 125000001433 C-terminal amino-acid group Chemical group 0.000 abstract 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 108700019146 Transgenes Proteins 0.000 abstract 1
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- A61K38/166—Streptokinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08710305 | 1996-09-17 | ||
| US08/710,305 US5801012A (en) | 1996-09-17 | 1996-09-17 | Methods and compositions for generating angiostatin |
| PCT/US1997/016539 WO1998015574A1 (en) | 1996-09-17 | 1997-09-17 | Methods and compositions for generating angiostatin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4422797A true AU4422797A (en) | 1998-05-05 |
Family
ID=24853480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU44227/97A Abandoned AU4422797A (en) | 1996-09-17 | 1997-09-18 | Methods and compositions for generating angiostatin |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US5801012A (enExample) |
| EP (2) | EP0964869B1 (enExample) |
| JP (1) | JP4160121B2 (enExample) |
| AT (1) | ATE329926T1 (enExample) |
| AU (1) | AU4422797A (enExample) |
| CA (1) | CA2265550A1 (enExample) |
| DE (1) | DE69736129T2 (enExample) |
| ES (1) | ES2267151T3 (enExample) |
| WO (1) | WO1998015574A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5945403A (en) * | 1997-05-30 | 1999-08-31 | The Children's Medical Center Corporation | Angiostatin fragments and method of use |
| US7297331B2 (en) * | 1996-04-03 | 2007-11-20 | The Rogosin Institute | Beads containing restricted cancer cells producing material suppressing cancer cell proliferation |
| CA2295925A1 (en) * | 1997-06-26 | 1999-01-07 | Karolinska Innovations Ab | Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| JP2002531385A (ja) * | 1998-11-25 | 2002-09-24 | ブリストル−マイヤーズ スクイブ カンパニー | アンジオスタチンおよびプラスミノゲンのクリングル５領域を含む組成物およびその使用方法 |
| EP1214346A1 (en) | 1999-09-15 | 2002-06-19 | Mogam Biotechnology Research Institute | A novel angiogenesis inhibitor |
| WO2001058921A2 (en) * | 2000-02-08 | 2001-08-16 | Northwestern University | Methods and compositions for generating angiostatin |
| CA2421251A1 (en) | 2000-09-05 | 2002-03-14 | Karolinska Innovations Ab | Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| US7420036B2 (en) | 2000-11-28 | 2008-09-02 | Waisman David M | Anti-angiogenic polypeptides |
| ITMI20011995A1 (it) * | 2001-09-26 | 2003-03-26 | Ist Naz Ricerca Sul Cancro | Sostanze ad attivita' antinfiammatoria |
| US7285277B2 (en) * | 2002-03-15 | 2007-10-23 | Mogam Biotechnology Research Institute | Anticancer agent |
| WO2004005248A1 (en) * | 2002-07-02 | 2004-01-15 | Novartis Ag | Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap) |
| WO2004054517A2 (en) * | 2002-12-13 | 2004-07-01 | Mediomics, Llc | Compositions and methods for inhibiting tumor growth and metastasis |
| US7141035B2 (en) * | 2003-03-28 | 2006-11-28 | Sherwood Services Ag | Catheter with occlusion resistant tip |
| US7090654B2 (en) * | 2003-03-28 | 2006-08-15 | Sherwood Services Ag | Catheter with occlusion resistant tip |
| US7776005B2 (en) * | 2003-03-28 | 2010-08-17 | Covidien Ag | Triple lumen catheter with occlusion resistant tip |
| CN1889929B (zh) * | 2003-11-14 | 2013-04-10 | 阿尔萨公司 | 药物递送媒介物中的赋形剂 |
| US20050281879A1 (en) * | 2003-11-14 | 2005-12-22 | Guohua Chen | Excipients in drug delivery vehicles |
| US9913962B2 (en) | 2004-11-04 | 2018-03-13 | Covidien Ag | Catheter insertion apparatus |
| US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
| WO2009100617A1 (zh) * | 2008-02-04 | 2009-08-20 | Shanghai First People's Hospital | 抑制血管新生的多肽及其应用 |
| WO2010151573A1 (en) | 2009-06-26 | 2010-12-29 | Tyco Healthcare Group Lp | Catheterization system |
| CA2715857A1 (en) | 2009-09-30 | 2011-03-30 | Tyco Healthcare Group Lp | Medical catheter having a design providing low recirculation and reversibility |
| US9072867B2 (en) | 2011-09-30 | 2015-07-07 | Covidien Lp | Catheter with external flow channel |
| US8747343B2 (en) | 2011-09-30 | 2014-06-10 | Covidien Lp | Hemodialysis catheter with improved side opening design |
| US9216163B2 (en) | 2013-05-20 | 2015-12-22 | Kyorin Pharmaceutical Co., Ltd. | Method of inhibiting angiogenesis |
| CA3167217A1 (en) | 2020-01-13 | 2021-07-22 | Durect Corporation | Sustained release drug delivery systems with reduced impurities and related methods |
| CN116940358A (zh) | 2021-01-12 | 2023-10-24 | 度勒科特公司 | 持续释放药物递送系统和有关的方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2431342C3 (de) * | 1973-07-27 | 1978-10-26 | Behringwerke Ag, 3550 Marburg | Verfahren zur Messung des Plasminogengehaltes durch Bestimmung der Bildung von Fibrin in einer Probe |
| US4968494A (en) * | 1987-03-27 | 1990-11-06 | Merck & Co., Inc. | Methods and compositions for thrombolytic therapy |
| US5135919A (en) | 1988-01-19 | 1992-08-04 | Children's Medical Center Corporation | Method and a pharmaceutical composition for the inhibition of angiogenesis |
| US5021404A (en) | 1988-04-20 | 1991-06-04 | The Children's Medical Center Corporation | Angiostatic collagen modulators |
| DE68927904T2 (de) | 1988-09-01 | 1997-09-04 | Takeda Chemical Industries Ltd | Fumagillol-Derivate |
| PT93847A (pt) | 1989-04-24 | 1990-11-20 | Harvard College | Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem |
| US5290807A (en) | 1989-08-10 | 1994-03-01 | Children's Medical Center Corporation | Method for regressing angiogenesis using o-substituted fumagillol derivatives |
| US5192744A (en) | 1990-01-12 | 1993-03-09 | Northwestern University | Method of inhibiting angiogenesis of tumors |
| US5504074A (en) | 1993-08-06 | 1996-04-02 | Children's Medical Center Corporation | Estrogenic compounds as anti-angiogenic agents |
| US5639725A (en) | 1994-04-26 | 1997-06-17 | Children's Hospital Medical Center Corp. | Angiostatin protein |
| US5945403A (en) | 1997-05-30 | 1999-08-31 | The Children's Medical Center Corporation | Angiostatin fragments and method of use |
| CN1636594B (zh) * | 1994-04-26 | 2012-08-29 | 儿童医学中心公司 | 血管生成抑制素和用于抑制血管生成的方法 |
| US5837682A (en) | 1996-03-08 | 1998-11-17 | The Children's Medical Center Corporation | Angiostatin fragments and method of use |
| ATE368051T1 (de) | 1995-04-26 | 2007-08-15 | Childrens Medical Center | Angiostatinfragmente und verfahren für deren verwendung |
| US5861372A (en) | 1996-02-22 | 1999-01-19 | The Children's Medical Center Corporation | Aggregate angiostatin and method of use |
| WO1996041194A1 (en) | 1995-06-07 | 1996-12-19 | The Children's Medical Center Corporation | Diagnosis, prognosis and monitoring of angiogenesis dependent diseases |
| DE19529223A1 (de) * | 1995-08-09 | 1997-02-13 | Boehringer Mannheim Gmbh | Verwendung von Plasminogenaktivatoren zum lokalen Knochenaufbau |
| CN1202932A (zh) | 1995-10-23 | 1998-12-23 | 儿童医学中心公司 | 治疗用抗血管生成的组合物和方法 |
| US5854221A (en) | 1996-12-12 | 1998-12-29 | The Children's Medical Center Corporation | Endothelial cell proliferation inhibitor and method of use |
| CN1554444A (zh) | 1995-12-13 | 2004-12-15 | ��ͯҽѧ���Ĺ�˾ | 内皮细胞增殖抑制剂及其应用方法 |
| BR9708911A (pt) | 1996-05-03 | 1999-08-03 | Abbott Lab | Composto fragmento de peptídeo processo par tratar uma doença em um paciente em necessidade de terapia antioangiogênese composição polinucleotídeo único ou de duplo-filamento isolado vetor e processo para produzir um fragmento de peptídeo de kringle 5 ou proteína de fusão de kringle 5 solúvel |
| CA2295925A1 (en) | 1997-06-26 | 1999-01-07 | Karolinska Innovations Ab | Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
-
1996
- 1996-09-17 US US08/710,305 patent/US5801012A/en not_active Expired - Fee Related
-
1997
- 1997-09-17 JP JP51753898A patent/JP4160121B2/ja not_active Expired - Fee Related
- 1997-09-17 WO PCT/US1997/016539 patent/WO1998015574A1/en not_active Ceased
- 1997-09-17 CA CA002265550A patent/CA2265550A1/en not_active Abandoned
- 1997-09-17 EP EP97942549A patent/EP0964869B1/en not_active Expired - Lifetime
- 1997-09-17 DE DE69736129T patent/DE69736129T2/de not_active Expired - Fee Related
- 1997-09-17 ES ES97942549T patent/ES2267151T3/es not_active Expired - Lifetime
- 1997-09-17 AT AT97942549T patent/ATE329926T1/de not_active IP Right Cessation
- 1997-09-17 EP EP06112574A patent/EP1705184A1/en not_active Withdrawn
- 1997-09-18 AU AU44227/97A patent/AU4422797A/en not_active Abandoned
- 1997-12-16 US US08/991,761 patent/US6576609B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998015574A1 (en) | 1998-04-16 |
| EP1705184A1 (en) | 2006-09-27 |
| ES2267151T3 (es) | 2007-03-01 |
| JP4160121B2 (ja) | 2008-10-01 |
| US5801012A (en) | 1998-09-01 |
| CA2265550A1 (en) | 1998-04-16 |
| EP0964869B1 (en) | 2006-06-14 |
| DE69736129D1 (de) | 2006-07-27 |
| EP0964869A1 (en) | 1999-12-22 |
| US6576609B1 (en) | 2003-06-10 |
| EP0964869A4 (en) | 2003-06-04 |
| ATE329926T1 (de) | 2006-07-15 |
| JP2001502534A (ja) | 2001-02-27 |
| DE69736129T2 (de) | 2007-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4422797A (en) | Methods and compositions for generating angiostatin | |
| PL336311A1 (en) | Osteoprotegeric bonding proteins and receptors | |
| DK0662827T3 (da) | Terapeutiske og diagnostiske fremgangsmåder og sammensætninger baseret på Notch-proteiner og nucleinsyrer | |
| DE69535375D1 (de) | Lösliche polypeptidfraktionen des lag-3-proteins; verfahren zur herstellung; therapeutische zusamensetzung; antiidiotypischer antikörper | |
| AU2894289A (en) | Domain-modified constant region antibodies | |
| NZ227787A (en) | Peptides and compositions having growth hormone regulatory effects | |
| KR900700116A (ko) | 뼈-유도 단백질 | |
| NZ504114A (en) | Vitamin k-dependent polypeptides such as protein C where substitution at amino acid sites 11, 12, 29, 33 or 34 affects membrane binding affinity of the protein and ultimately blood clotting ability | |
| NZ236511A (en) | Polypeptides containing sequences from residues 61 to 82 or 104 to 129 of human il-4 or subsequences thereof; antibodies and pharmaceutical compositions | |
| DK0901526T3 (da) | Cortistatin: neuropeptider, sammensætninger og metoder | |
| DK0953576T3 (da) | Aktivt hedgehog-proteinkonjugat, fremgangsmåde til fremstilling heraf og anvendelse | |
| KR980002066A (ko) | 변이형 인간 성장호르몬 및 그의 용도 | |
| Camacho et al. | Limited proteolysis of tumor cells increases their plasmin-binding ability | |
| ATE292471T1 (de) | Peptide des tsp-i-rezeptors cd36 zur behandlung von krankheiten welche durch eine fehlregulation von tgf-beta1 verursacht werden | |
| WO2001058921A3 (en) | Methods and compositions for generating angiostatin | |
| DE3883315D1 (de) | Neue fibrinolytische enzyme. | |
| PT639225E (pt) | Polipeptidos e peptidos novos acidos nucleicos que codificam para aqueles e sua utilizacao na area da terapia tumoral inflamacao ou imunologia | |
| KR900702017A (ko) | 혼성 단백질(bybrid proteins) | |
| DE59611005D1 (de) | Mutant des inhibitors des erythrina caffra typs und dessen verwendung zur reinigung von serinproteasen |